Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Bratisl Lek Listy ; 118(2): 95-100, 2017.
Article in English | MEDLINE | ID: mdl-28814090

ABSTRACT

OBJECTIVES: The aim of the current study was to investigate the possible radioprotective effects of melatonin against hepatic radioiodine (RAI) toxicity. METHODS: Thirty-six rats were randomly divided into three groups: untreated control (Group 1); oral radioiodine (RAI, 111 MBq) administrated rats (Group 2), and melatonin group (oral RAI and daily intraperitoneal injection of 12 mg/kg melatonin-Group 3). In the third group, melatonin administration was started two days before and continued for five days after RAI administration. Twenty-four hours after the administration of the last dose of melatonin, liver samples were taken for biochemical and histopathological evaluation. RESULTS: Oxidative stress parameters demonstrated that melatonin treatment decreased the tissue malondialdehyde (MDA), advanced the oxidation protein products (AOPP) levels, and increased the total-SH (sulphydryl) levels when compared with RAI group. The differences were statistically significant between these groups for all parameters (p < 0.05). The histopathological damage in the melatonin-treated group was significantly less than the damage in RAI group (p < 0.05 for all pathological parameters). CONCLUSION: The results of this study demonstrated that melatonin reduced the harmful effects of RAI treatment on the liver. Anti-inflammatory and antioxidant activities are likely to be involved in the mechanism underlying the radio-protective effects of melatonin (Tab. 3, Fig. 1, Ref. 30).


Subject(s)
Antioxidants/pharmacology , Iodine Radioisotopes/toxicity , Liver/drug effects , Melatonin/pharmacology , Protective Agents/pharmacology , Animals , Iodine Radioisotopes/adverse effects , Lipid Peroxidation/drug effects , Liver/metabolism , Male , Malondialdehyde/metabolism , Oxidative Stress/drug effects , Random Allocation , Rats , Rats, Wistar
2.
Bratisl Lek Listy ; 115(9): 544-9, 2014.
Article in English | MEDLINE | ID: mdl-25318912

ABSTRACT

AIM: The present study aimed to evaluate intra-abdominal adhesion generating potential of Ankaferd Blood Stopper (ABS), which was used as postoperative hemostatic agent in the rats that underwent surgery, in comparison with Ca-alginate. MATERIAL AND METHOD: Totally, 30 rats were randomized into 4 groups. In the control group, 1x1 cm peritoneum was removed from the right lower quadrant after cecal abrasion. In the other two study groups, the same procedure was performed after Ankaferd Blood Stopper and Ca-alginate application respectively. RESULTS were evaluated both histopathologically and by adhesion scoring methods. All results underwent statistical analysis. RESULTS: Comparing overall results, no statistically significant difference was found between the sham, control, ABS and Ca-alginate groups (p = 0.099). Paired group comparisons revealed no statistically significant difference between the sham group and the control, ABS, and Ca-alginate groups (p = 0.222, p = 0.222, and p = 0.833 respectively). It was observed that there was no statistically significant difference between the control and ABS groups (p = 0.505), but there was a statistically significant difference between the control and Ca-alginate groups with Bonferroni correction (p = 0.028). Histopathological examination revealed no statistical difference between the groups. CONCLUSION: In conclusion, intra-abdominal adhesion generating potentials of Ca-alginate and ABS were experimentally evaluated and macroscopic and microscopic comparisons revealed no significant difference between sham, control, Ca-alginate, and ABS groups (Fig. 8, Ref. 36). Text in PDF www.elis.sk. agent.


Subject(s)
Abdominal Cavity , Alginates/therapeutic use , Cecal Diseases/etiology , Hemostatics/therapeutic use , Plant Extracts/therapeutic use , Postoperative Hemorrhage/prevention & control , Animals , Cecal Diseases/pathology , Female , Glucuronic Acid/therapeutic use , Hexuronic Acids/therapeutic use , Laparotomy/adverse effects , Postoperative Hemorrhage/etiology , Rats , Rats, Wistar , Tissue Adhesions/etiology
3.
Bratisl Lek Listy ; 113(12): 692-7, 2012.
Article in English | MEDLINE | ID: mdl-23173625

ABSTRACT

AIM: Our goal was to determine the effects of a diosmine-hesperidine combination on wound healing in a rat model of colonic anastomosis. MATERIALS AND METHODS: In this study, 20 Wistar Albino female rats were randomized into four experimental groups containing five rats in each group. A segment of 1 cm of colon was excised 4 cm proximally to the peritoneal reflection in all rats without carrying out any mechanical or antibacterial bowel preparation. Colonic anastomosis was performed with interrupted, inverting sutures of 6/0 polypropylene. Beginning from the first postoperative day, the rats in Groups II and IV received 100 mg/kg per day of diosmine-hesperidine via orogastic route by 4F fine feeding catheter. RESULTS: A significant difference was detected between groups in terms of their hydroxyproline levels (p<0.05); the hydroxyproline level of Group I was significantly lower than that of the other groups while no significant difference was noted between Groups II and III. CONCLUSION: The administration of diosmine-hesperidine increased the amount of collagen and bursting pressures at the anastomotic site and thus had favorable influences on the healing of colonic anastomosis (Tab. 1, Fig. 3, Ref. 33).


Subject(s)
Anastomosis, Surgical , Colon/surgery , Diosmin/administration & dosage , Hesperidin/administration & dosage , Wound Healing/drug effects , Animals , Colon/metabolism , Drug Combinations , Female , Hydroxyproline/metabolism , Rats , Rats, Wistar , Tensile Strength , Wound Healing/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...